Feisty Rivals Take On Eli Lilly, Novo Nordisk On Weight Loss: Eli Lilly's Mounjaro and Novo Nordisk's Ozempic and Wegovy are headliners in the expected ...
investors.com/etfs-and-funds/etfs/weight-loss-drugs-feisty-rivals-take-on-eli-lilly-novo-nordisk/
$SLN - Silence Therapeutics: Multiple 2024 Catalysts Make This mRNA Biotech Worth A Look. seekingalpha.com/article/4673206-silence-therapeutics-multiple-2024-catalysts-makes-this-mrna-biotech-worth-a-look?source=feed_f&utm_campaign=twitter_automated&utm_content=article&utm_medium=social&utm_source=twitter_automated #investing #economy #trading
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics